Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole for tinnitus treatment
IRCT20100126003181N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of riluzole in tinnitus, sponsored by Tehran University of Medical Sciences. Started Dec 2017; status: completed.
02
Drugs
riluzole
03
Conditions
tinnitus
Beyond the preview
Go deeper on IRCT20100126003181N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100126003181N2.